OMNICELL INC (OMCL)
US68213N1090 - Common Stock
Overall OMCL gets a fundamental rating of 4 out of 10. We evaluated OMCL against 187 industry peers in the Health Care Equipment & Supplies industry. While OMCL seems to be doing ok healthwise, there are quite some concerns on its profitability. OMCL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year OMCL was profitable.
In the past year OMCL had a positive cash flow from operations.
Of the past 5 years OMCL 4 years were profitable.
Each year in the past 5 years OMCL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of OMCL (-0.77%) is better than 68.28% of its industry peers.
OMCL has a better Return On Equity (-1.44%) than 69.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.77% | ||
| ROE | -1.44% | ||
| ROIC | N/A |
ROA(3y)0.99%
ROA(5y)1.94%
ROE(3y)1.86%
ROE(5y)3.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OMCL has a worse Gross Margin (41.44%) than 67.20% of its industry peers.
In the last couple of years the Gross Margin of OMCL has declined.
The Profit Margin and Operating Margin are not available for OMCL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.44% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-1.62%
2. Health
2.1 Basic Checks
OMCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OMCL has been increased compared to 1 year ago.
OMCL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OMCL has about the same debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.85 indicates that OMCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.85, OMCL is in line with its industry, outperforming 58.06% of the companies in the same industry.
OMCL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 4.84 | ||
| Altman-Z | 1.85 |
ROIC/WACCN/A
WACC7.98%
2.3 Liquidity
OMCL has a Current Ratio of 1.05. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
OMCL has a Current ratio of 1.05. This is amonst the worse of the industry: OMCL underperforms 91.94% of its industry peers.
OMCL has a Quick Ratio of 1.05. This is a bad value and indicates that OMCL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of OMCL (0.95) is worse than 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
OMCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.13%.
Measured over the past years, OMCL shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.69% on average per year.
OMCL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.27%.
OMCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.82% yearly.
EPS 1Y (TTM)-25.13%
EPS 3Y-9.06%
EPS 5Y-1.69%
EPS Q2Q%-9.68%
Revenue 1Y (TTM)-10.27%
Revenue growth 3Y8.74%
Revenue growth 5Y7.82%
Sales Q2Q%-5.44%
3.2 Future
Based on estimates for the next years, OMCL will show a small growth in Earnings Per Share. The EPS will grow by 3.77% on average per year.
Based on estimates for the next years, OMCL will show a quite strong growth in Revenue. The Revenue will grow by 10.50% on average per year.
EPS Next Y-10.1%
EPS Next 2Y-1.59%
EPS Next 3Y3.77%
EPS Next 5YN/A
Revenue Next Year-3.34%
Revenue Next 2Y0.85%
Revenue Next 3Y2.13%
Revenue Next 5Y10.5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
OMCL is valuated quite expensively with a Price/Earnings ratio of 31.27.
OMCL's Price/Earnings ratio is a bit cheaper when compared to the industry. OMCL is cheaper than 73.12% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.40. OMCL is around the same levels.
The Price/Forward Earnings ratio is 24.17, which indicates a rather expensive current valuation of OMCL.
Based on the Price/Forward Earnings ratio, OMCL is valued a bit cheaper than 76.88% of the companies in the same industry.
OMCL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.67, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.27 | ||
| Fwd PE | 24.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMCL indicates a somewhat cheap valuation: OMCL is cheaper than 68.82% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, OMCL is valued cheaply inside the industry as 92.47% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.53 | ||
| EV/EBITDA | 32.97 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.59%
EPS Next 3Y3.77%
5. Dividend
5.1 Amount
OMCL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OMNICELL INC
NASDAQ:OMCL (1/6/2025, 8:00:02 PM)
After market: 44.71 0 (0%)44.71
-0.61 (-1.35%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.08%
Inst Owner Change-0.01%
Ins Owners1.27%
Ins Owner Change2.74%
Market Cap2.07B
Analysts74.67
Price Target57.7 (29.05%)
Short Float %4.6%
Short Ratio3.38
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)140.61%
Min EPS beat(2)35.6%
Max EPS beat(2)245.61%
EPS beat(4)4
Avg EPS beat(4)130.9%
Min EPS beat(4)35.6%
Max EPS beat(4)245.61%
EPS beat(8)8
Avg EPS beat(8)170.75%
EPS beat(12)10
Avg EPS beat(12)115.18%
EPS beat(16)14
Avg EPS beat(16)90.47%
Revenue beat(2)1
Avg Revenue beat(2)2.53%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)6.33%
Revenue beat(4)2
Avg Revenue beat(4)1.57%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.33%
Revenue beat(8)5
Avg Revenue beat(8)1.58%
Revenue beat(12)5
Avg Revenue beat(12)-0.02%
Revenue beat(16)7
Avg Revenue beat(16)0.06%
PT rev (1m)-4.65%
PT rev (3m)27.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.74%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)22.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.27 | ||
| Fwd PE | 24.17 | ||
| P/S | 1.95 | ||
| P/FCF | 17.53 | ||
| P/OCF | 12.2 | ||
| P/B | 1.68 | ||
| P/tB | 8.61 | ||
| EV/EBITDA | 32.97 |
EPS(TTM)1.43
EY3.2%
EPS(NY)1.85
Fwd EY4.14%
FCF(TTM)2.55
FCFY5.71%
OCF(TTM)3.67
OCFY8.2%
SpS22.98
BVpS26.58
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.77% | ||
| ROE | -1.44% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.44% | ||
| FCFM | 11.1% |
ROA(3y)0.99%
ROA(5y)1.94%
ROE(3y)1.86%
ROE(5y)3.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.22%
GM growth 5Y-1.62%
F-Score4
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 4.84 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 61.49% | ||
| Cap/Sales | 4.85% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 271.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.85 |
F-Score4
WACC7.98%
ROIC/WACCN/A
Cap/Depr(3y)70.91%
Cap/Depr(5y)83.54%
Cap/Sales(3y)4.88%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.13%
EPS 3Y-9.06%
EPS 5Y-1.69%
EPS Q2Q%-9.68%
EPS Next Y-10.1%
EPS Next 2Y-1.59%
EPS Next 3Y3.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.27%
Revenue growth 3Y8.74%
Revenue growth 5Y7.82%
Sales Q2Q%-5.44%
Revenue Next Year-3.34%
Revenue Next 2Y0.85%
Revenue Next 3Y2.13%
Revenue Next 5Y10.5%
EBIT growth 1Y20.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.39%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y2668.7%
FCF growth 3Y-1.27%
FCF growth 5Y20.51%
OCF growth 1Y207.61%
OCF growth 3Y-0.87%
OCF growth 5Y11.73%